Marc Dechamps

CEO at Bioxodes

Speaker

Marc Dechamps is a biologist with more than 35 years of experience in the pharmaceutical industry, including at GSK and ViiVHealthcare. His extensive expertise in developing new products ranges from infectious diseases, immunological disorders, oncology and CNS disorders to vaccines. In 2016, Marc founded XMF consulting, a company which supports biotech and biopharma businesses with strategic advice and management leadership. He has served as managing director of Delphi Genetics, a CDMO, and interim CEO of eTheRNA Immunotherapies, an mRNA biotech firm. Next to his busy role as Bioxodes CEO, Marc serves as president of the board of Investsud Tech (group InvestSud) and as board member of HealthTech for Care (HT4C). He is a co-academic director for the advanced masters in biotech & medtech ventures at the Solvay Brussels School of Economics & Management, and recently joined Ose Immunotherapeutics as an independent board member.